Dr. Darren Candow

The safety profile is exceptional.

I mean, if you want to do 5 grams or more, I don't see any reason why not.

Do they need to be taking the 10 and 20 grams?

We just don't have the data to support that.

But a low dose, 2 to 3, 5 grams is totally viable.

Just subjective questionnaires, how they're feeling, things like that.

It's too dangerous in a sense because we just don't know yet.

And to get an ethics board approval at a research institution is very difficult, even for teenagers and adults.

under the age of 18 so i know stacy is in our big myths paper is concluded that we need more randomized control trials a big trial because we definitely want to get this one right and make sure it's 100 safe not just for the unborn child but also for the mother um so there's going to be a lot more data to come out but overall there's no reason to suggest there's any issues whatsoever yeah

I think down the road, when they look at the hypoxic environment of fetal growth, I think it probably will get approved.

But we're going to need a lot more clinical data to suggest it's safe and maybe a pilot study in that.

The issues with pilot studies are usually low sample size.

So then from a feasibility perspective, it might be have it actually I can see it in a multi country study.

to get a lot of people in different countries to come together and make the sample size that high.

So that's something to look forward to as well, especially in addition to the neurodegenerative diseases.

Or the motor unit recruitment or maybe muscle activation.

So there's a whole plethora of ideas from a balance, agility, coordination perspective.

It could be that they're able to exercise at a higher capacity, sort of almost hyper accelerate muscle development.

Those are all the things that are in its infancy to look at.

Again, there hasn't been a study to look at blood biomarkers for like liver and kidney enzymes.